LGALS3 and steatosis: The main findings stemming from the present study are: 1) Gal-3 inhibition is beneficial against steatosis and liver fibrosis in a 3D spheroid model; 2) genes involved in beta-oxidation may be affected without significant changes in fatty acid synthesis and lipid transport.